These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Does therapeutic equivalence follow bioequivalence? A randomized trial to assess clinical effects after switching from Clozaril to generic clozapine (gen-clozapine). Oluboka O, Stewart S, Landry S, Adams S. J Clin Pharmacol; 2010 May; 50(5):531-5. PubMed ID: 20089825 [Abstract] [Full Text] [Related]
3. Clinical effects of a randomized switch of patients from clozaril to generic clozapine. Kluznik JC, Walbek NH, Farnsworth MG, Melstrom K. J Clin Psychiatry; 2001 May; 62 Suppl 5():14-7; discussion 23-4. PubMed ID: 11305843 [Abstract] [Full Text] [Related]
4. Generic clozapine: a cost-saving alternative to brand name clozapine? Tse G, Thompson D, Procyshyn RM. Pharmacoeconomics; 2003 May; 21(1):1-11. PubMed ID: 12484800 [Abstract] [Full Text] [Related]
5. Bioequivalence of clozapine orally disintegrating 100-mg tablets compared with clozapine solid oral 100-mg tablets after multiple doses in patients with schizophrenia. Golden G, Honigfeld G. Clin Drug Investig; 2008 May; 28(4):231-9. PubMed ID: 18345713 [Abstract] [Full Text] [Related]
6. Clinical equivalence of generic clozapine. Healy DJ, Taylor S, Goldman M, Barry K, Blow F, Milner KK. Community Ment Health J; 2005 Aug; 41(4):393-8. PubMed ID: 16335349 [Abstract] [Full Text] [Related]
12. Evaluation of an interchangeability switch in patients treated with clozapine: A retrospective review. Alessi-Severini S, Honcharik PL, Simpson KD, Eleff MK, Collins DM. J Clin Psychiatry; 2006 Jul; 67(7):1047-54. PubMed ID: 16889447 [Abstract] [Full Text] [Related]
13. Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia. Naber D, Riedel M, Klimke A, Vorbach EU, Lambert M, Kühn KU, Bender S, Bandelow B, Lemmer W, Moritz S, Dittmann RW. Acta Psychiatr Scand; 2005 Feb; 111(2):106-15. PubMed ID: 15667429 [Abstract] [Full Text] [Related]
14. Case reports of the reemergence of psychotic symptoms after conversion from brand-name clozapine to a generic formulation. Mofsen R, Balter J. Clin Ther; 2001 Oct; 23(10):1720-31. PubMed ID: 11726006 [Abstract] [Full Text] [Related]
15. Effects of switching inpatients with treatment-resistant schizophrenia from clozapine to risperidone. Still DJ, Dorson PG, Crismon ML, Pousson C. Psychiatr Serv; 1996 Dec; 47(12):1382-4. PubMed ID: 9117479 [Abstract] [Full Text] [Related]
16. Switching from clozapine to zotepine in patients with schizophrenia: a 12-week prospective, randomized, rater blind, and parallel study. Lin CC, Chiu HJ, Chen JY, Liou YJ, Wang YC, Chen TT, Bai YM. J Clin Psychopharmacol; 2013 Apr; 33(2):211-4. PubMed ID: 23422395 [Abstract] [Full Text] [Related]
18. Converting from brand-name to generic clozapine: a review of effectiveness and tolerability data. Bobo WV, Stovall JA, Knostman M, Koestner J, Shelton RC. Am J Health Syst Pharm; 2010 Jan 01; 67(1):27-37. PubMed ID: 20044366 [Abstract] [Full Text] [Related]
19. Generic replacement of clozapine: a simple decision model from a Canadian perspective. Layton S, Barbeau M. Curr Med Res Opin; 2004 Apr 01; 20(4):453-9. PubMed ID: 15119982 [Abstract] [Full Text] [Related]
20. Generic Olanzapine Substitution in Patients With Schizophrenia: Assessment of Serum Concentrations and Therapeutic Response After Switching. Italiano D, Bruno A, Santoro V, Lanza G, Muscatello MR, Zoccali R, Spina E. Ther Drug Monit; 2015 Dec 01; 37(6):827-30. PubMed ID: 25830930 [Abstract] [Full Text] [Related] Page: [Next] [New Search]